Findings from University of Ulsan in Solid Cancer Reported [Safety and Efficacy of Trastuzumab Biosimilar Plus Irinotecan or Gemcitabine In Patients With Previously Treated Her2 (Erbb2)-positive Non-breast/ Non-gastric Solid Tumors: a Phase Ii ...]

Press/Media: Press / Media

Period	2023 Sept 13

Media coverage

Title	Findings from University of Ulsan in Solid Cancer Reported [Safety and Efficacy of Trastuzumab Biosimilar Plus Irinotecan or Gemcitabine In Patients With Previously Treated Her2 (Erbb2)-positive Non-breast/ Non-gastric Solid Tumors: a Phase Ii ...]
Media name/outlet	South Korea Daily Report
Country/Territory	United States
Date	23/9/13
URL	metabase.moreover.com/noarticleurl?type=psh&lni=695F-00G1-DY7R-R37T-00000-00
Persons	Seok-Jun Yoon, SeokjunJoon Yoon